Conference Reports for NATAP
The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2021
Back
 
LIVER-DISTRIBUTED FXR AGONIST TERN-101 DEMONSTRATES
FAVORABLE SAFETY AND EFFICACY PROFILE IN NASH PHASE 2a LIFT STUDY
AASLD 2021 Nov 12-15